pubmed-article:17166826 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C1367389 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C0205102 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C0031727 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C0036849 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C0205396 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C1442518 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C1148926 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C1552652 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C1880156 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C1552685 | lld:lifeskim |
pubmed-article:17166826 | lifeskim:mentions | umls-concept:C1705195 | lld:lifeskim |
pubmed-article:17166826 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:17166826 | pubmed:dateCreated | 2007-2-19 | lld:pubmed |
pubmed-article:17166826 | pubmed:abstractText | Numerous assay methods have been developed to identify small-molecule effectors of protein kinases, but no single method can be applied to all isolated kinases. The authors developed a set of 3 high-throughput screening (HTS)-compatible biochemical assays that can measure 3 mechanistically distinct properties of a kinase active site, with the goal that at least 1 of the 3 would be applicable to any kinase selected as a target for drug discovery efforts. Two assays measure catalytically active enzyme: A dissociation-enhanced lanthanide fluoroimmuno assay (DELFIA) uses an antibody to quantitate the generation of phosphorylated substrate; a second assay uses luciferase to measure the consumption of adenosine triphosphate (ATP) during either phosphoryl-transfer to a peptide substrate or to water (intrinsic ATPase activity). A third assay, which is not dependent on a catalytically active enzyme, measures the competition for binding to kinase between an inhibitor and a fluorescent ATP binding site probe. To evaluate the suitability of these assays for drug discovery, the authors compared their ability to identify inhibitors of a nonreceptor protein tyrosine kinase from the Tec family, interleukin-2-inducible T cell kinase (ITK). The 3 assays agreed on 57% of the combined confirmed hit set identified from screening a 10,208-compound library enriched with known kinase inhibitors and molecules that were structurally similar. Among the 3 assays, the one measuring intrinsic ATPase activity produced the largest number of unique hits, the fewest unique misses, and the most comprehensive hit set, missing only 2.7% of the confirmed inhibitors identified by the other 2 assays combined. Based on these data, all 3 assay formats are viable for screening and together provide greater options for assay design depending on the targeted kinase. | lld:pubmed |
pubmed-article:17166826 | pubmed:language | eng | lld:pubmed |
pubmed-article:17166826 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17166826 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17166826 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17166826 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17166826 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17166826 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17166826 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17166826 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17166826 | pubmed:month | Feb | lld:pubmed |
pubmed-article:17166826 | pubmed:issn | 1087-0571 | lld:pubmed |
pubmed-article:17166826 | pubmed:author | pubmed-author:PullenSteven... | lld:pubmed |
pubmed-article:17166826 | pubmed:author | pubmed-author:SnowRoger JRJ | lld:pubmed |
pubmed-article:17166826 | pubmed:author | pubmed-author:JakesScottS | lld:pubmed |
pubmed-article:17166826 | pubmed:author | pubmed-author:ProkopowiczAn... | lld:pubmed |
pubmed-article:17166826 | pubmed:author | pubmed-author:MorelockMauri... | lld:pubmed |
pubmed-article:17166826 | pubmed:author | pubmed-author:NelsonRichard... | lld:pubmed |
pubmed-article:17166826 | pubmed:author | pubmed-author:KashemMohamme... | lld:pubmed |
pubmed-article:17166826 | pubmed:author | pubmed-author:WolakJohn PJP | lld:pubmed |
pubmed-article:17166826 | pubmed:author | pubmed-author:HomonCarol... | lld:pubmed |
pubmed-article:17166826 | pubmed:author | pubmed-author:YinglingJeffr... | lld:pubmed |
pubmed-article:17166826 | pubmed:author | pubmed-author:JonesJessi... | lld:pubmed |
pubmed-article:17166826 | pubmed:author | pubmed-author:RogersGeorge... | lld:pubmed |
pubmed-article:17166826 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17166826 | pubmed:volume | 12 | lld:pubmed |
pubmed-article:17166826 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17166826 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17166826 | pubmed:pagination | 70-83 | lld:pubmed |
pubmed-article:17166826 | pubmed:dateRevised | 2011-5-23 | lld:pubmed |
pubmed-article:17166826 | pubmed:meshHeading | pubmed-meshheading:17166826... | lld:pubmed |
pubmed-article:17166826 | pubmed:meshHeading | pubmed-meshheading:17166826... | lld:pubmed |
pubmed-article:17166826 | pubmed:meshHeading | pubmed-meshheading:17166826... | lld:pubmed |
pubmed-article:17166826 | pubmed:meshHeading | pubmed-meshheading:17166826... | lld:pubmed |
pubmed-article:17166826 | pubmed:meshHeading | pubmed-meshheading:17166826... | lld:pubmed |
pubmed-article:17166826 | pubmed:meshHeading | pubmed-meshheading:17166826... | lld:pubmed |
pubmed-article:17166826 | pubmed:meshHeading | pubmed-meshheading:17166826... | lld:pubmed |
pubmed-article:17166826 | pubmed:meshHeading | pubmed-meshheading:17166826... | lld:pubmed |
pubmed-article:17166826 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17166826 | pubmed:articleTitle | Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors. | lld:pubmed |
pubmed-article:17166826 | pubmed:affiliation | Boehringer Ingelheim Pharmaceuticals, Inc., Department of Medicinal Chemistry, Ridgefield, CT 06877-0368, USA. mkashem@rdg.boehringer-ingelheim.com | lld:pubmed |
pubmed-article:17166826 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17166826 | pubmed:publicationType | Comparative Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17166826 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17166826 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17166826 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17166826 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17166826 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17166826 | lld:pubmed |